{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:27:36Z","timestamp":1794853656314,"version":"4.9.1"},"reference-count":151,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/501100019725","name":"DEBRA Austria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2022,9,2]]},"DOI":"10.1080\/14712598.2022.2049229","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T16:34:05Z","timestamp":1646238845000},"page":"1137-1150","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Current developments in gene therapy for epidermolysis bullosa"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-3049","authenticated-orcid":false,"given":"Thomas","family":"Kocher","sequence":"first","affiliation":[{"name":"University Hospital of the Paracelsus Medical University Salzburg","place":["Salzburg, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-1524","authenticated-orcid":false,"given":"Igor","family":"Petkovic","sequence":"additional","affiliation":[{"name":"University Hospital of the Paracelsus Medical University Salzburg","place":["Salzburg, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5309-1936","authenticated-orcid":false,"given":"Johannes","family":"Bischof","sequence":"additional","affiliation":[{"name":"University Hospital of the Paracelsus Medical University Salzburg","place":["Salzburg, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-1789","authenticated-orcid":false,"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[{"name":"University Hospital of the Paracelsus Medical University Salzburg","place":["Salzburg, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18921"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.903"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1504"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.10.038"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature24487"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.658295"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2013.11.001"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35700"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088547"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.04.055"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130554"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15588"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.11.036"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.91"},{"key":"e_1_3_6_17_1","unstructured":"Holostem Terapie Avanzate s.r.l. Clinical trial to assess safety and efficacy of autologous cultured epidermal grafts containing epidermal stem cells genetically modified in patients with JEB (HOLOGENE17). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03490331?term=NCT03490331&draw=2&rank=1NLMIdentifier:NCT03490331"},{"key":"e_1_3_6_18_1","unstructured":"Holostem Terapie Avanzate s.r.l. Open-label pivotal clinical trial to confirm efficacy and safety of autologous grafts containing stem cells genetically modified for epidermis restoration in patients with junctional epidermolysis bullosa (HOLOGENE 5). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05111600?term=NCT05111600&draw=2&rank=1NLMIdentifier:NCT05111600"},{"key":"e_1_3_6_19_1","unstructured":"Holostem Terapie Avanzate s.r.l. Clinical trial to assess safety and efficacy of autologous cultured epidermal grafts containing epidermal stem cells genetically modified in patients with RDEB. (HOLOGENE7). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02984085?term=NCT02984085&draw=2&rank=1NLMIdentifier:NCT02984085"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.02.811"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/JID.2015.364"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126243"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010112"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.06.008"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.02.012"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.03.007"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2020.12.007"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.05.015"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.701"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1711-4"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.12.452037"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.08.018"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212222"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700435"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.07.029"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073326"},{"key":"e_1_3_6_37_1","unstructured":"Phoenicis Therapeutics AD-B Randomized. Intra-subject placebo-controlled multicenter multiple dose study evaluating safety proof of mechanism preliminary efficacy and systemic exposure in subjects with confirmed ddeb or rdeb diagnosis with one or more pathogenic mutations in exon 73 in the col7a1 gene. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03605069?term=NCT03605069&draw=2&rank=1NLMIdentifier:NCT03605069"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.10"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2016.57"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101609"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr465"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701152"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030762"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17075"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx669"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpet.36"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2660260"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/Mcb.14.12.8096"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.3.1156"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045383"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/1759-8753-5-7"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.17.3361"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1948"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.02.027"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09523"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225829"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0561-9"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.08.021"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801185-0.00008-8"},{"issue":"3","key":"e_1_3_6_60_1","first-page":"E44","article-title":"Double-nicking-based correction of junctional epidermolysis bullosa via COL17A1 reframing","volume":"30","author":"Bischof J","year":"2021","unstructured":"Bischof J, March OP, Haas SA, et al. Double-nicking-based correction of junctional epidermolysis bullosa via COL17A1 reframing. EXP DERMATOL 2021;30(3):E44\u2013E44.","journal-title":"EXP DERMATOL"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25053"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.04.016"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.TM118.000371"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.7b00760"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2008.08.007"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.58"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800940105"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.03.1146"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-008-0435-6"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2014.12.006"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1643"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.05.005"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1512028113"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.02.015"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.229"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8081"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay6812"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.19"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614775114"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.11.031"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.56"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.07.024"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/npjregenmed.2016.14"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2020.04.004"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.08.015"},{"key":"e_1_3_6_86_1","doi-asserted-by":"crossref","first-page":"e04766","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin S","unstructured":"Lin S, Staahl BT, Alla RK, et al. Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. Elife. 2014 Dec 15;3:e04766. PubMed PMID: 25497837; PubMed Central PMCID: PMCPMC4383097.","journal-title":"Elife"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20358-5"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep21264"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051318"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.02.006"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2015.04.024"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.02.002"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17946"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature24644"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0059-1"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0236-6"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0414-6"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0491-6"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01025-z"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19136-7"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0677-y"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00520-x"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.018"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22295-w"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01039-7"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab792"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0210-0"},{"key":"e_1_3_6_108_1","unstructured":"Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale. France. ex vivo gene therapy clinical trial for rdeb using genetically corrected autologous skin equivalent grafts (EBGraft). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04186650?term=NCT04186650&draw=2&rank=1NLMIdentifier:NCT04186650"},{"key":"e_1_3_6_109_1","unstructured":"Stanford University. Gene transfer for recessive dystrophic epidermolysis bullosa. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01263379?term=NCT01263379&draw=2&rank=1NLMIdentifier:NCT01263379"},{"key":"e_1_3_6_110_1","unstructured":"Abeona Therapeutics Inc. Phase 3 open-label clinical trial of eb-101 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04227106?term=NCT04227106&draw=2&rank=1NLMIdentifier:NCT04227106"},{"key":"e_1_3_6_111_1","unstructured":"College London K. Safety study of gene-modified autologous fibroblasts in recessive dystrophic epidermolysis bullosa. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02493816?term=NCT02493816&draw=2&rank=1NLMIdentifier:NCT02493816"},{"key":"e_1_3_6_112_1","unstructured":"Castle Creek Biosciences LLC. A study of fcx-007 for recessive dystrophic epidermolysis bullosa (RDEB). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02810951?term=NCT02810951&draw=2&rank=1NLMIdentifier:NCT02810951"},{"key":"e_1_3_6_113_1","unstructured":"Castle Creek Biosciences LLC. A study of fcx-007 for recessive dystrophic epidermolysis bullosa (DEFI-RDEB). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04213261?term=NCT04213261&draw=2&rank=1NLMIdentifier:NCT04213261"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1177\/0963689719857657"},{"key":"e_1_3_6_115_1","unstructured":"Krystal Biotech Inc. Topical beremagene geperpavec (kb103) gene therapy to restore functional collagen vii for the treatment of dystrophic epidermolysis bullosa (GEM-1). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03536143?term=NCT03536143&draw=2&rank=1NLMIdentifier:NCT03536143"},{"key":"e_1_3_6_116_1","unstructured":"Krystal Biotech Inc. The objective of this study is to compare the efficacy and safety of beremagene geperpavec (b-vec) topical gel with that of placebo for the treatment of dystrophic epidermolysis bullosa (DEB). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2022 Feb 09]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04491604 NLM Identifier:NCT04491604"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.07.005"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.09.011"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1907081116"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19507-0"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.02.019"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2012.00810.x"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-74"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.14"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-020-00656-y"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah6192"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.11.028"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.06.008"},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13054"},{"key":"e_1_3_6_131_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.9b13135"},{"key":"e_1_3_6_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113842"},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00282-6"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.280"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c04707"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.30"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-017-0137-2"},{"key":"e_1_3_6_138_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201708689"},{"key":"e_1_3_6_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.3"},{"key":"e_1_3_6_140_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00544"},{"key":"e_1_3_6_141_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010894"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1347"},{"key":"e_1_3_6_143_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.939"},{"key":"e_1_3_6_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.11.005"},{"key":"e_1_3_6_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.01.008"},{"key":"e_1_3_6_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.09.004"},{"key":"e_1_3_6_147_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47007"},{"key":"e_1_3_6_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.05.020"},{"key":"e_1_3_6_149_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101722"},{"key":"e_1_3_6_150_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz459"},{"key":"e_1_3_6_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4192"},{"key":"e_1_3_6_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09006-2"},{"key":"e_1_3_6_153_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01387"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2022.2049229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T23:54:39Z","timestamp":1770940479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2022.2049229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":151,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,2]]}},"alternative-id":["10.1080\/14712598.2022.2049229"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2022.2049229","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}